Viatris (VTRS) News Today $11.30 -0.04 (-0.35%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period S&P 500 Gains and Losses Today: Bank Earnings, Soft Inflation Help Boost IndexJanuary 17 at 8:46 PM | msn.comIs Viatris Inc. (VTRS) Among Wednesday’s Losers?January 16, 2025 | insidermonkey.comViatris Inc. (VTRS) 43rd Annual J.P. Morgan Healthcare Conference 2025 (Transcript)January 14, 2025 | seekingalpha.comIs Viatris (VTRS) the Best Medical Stock to Buy Under $20?January 12, 2025 | insidermonkey.comViatris Inc. stock falls Wednesday, underperforms marketJanuary 10, 2025 | marketwatch.comArgus Research Keeps Their Hold Rating on Viatris (VTRS)January 7, 2025 | markets.businessinsider.comViatris Inc. (VTRS) Stock ForecastsJanuary 7, 2025 | finance.yahoo.comViatris to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 7, 2025 | prnewswire.comViatris: Looking At High Free Cash Flow Yield As Business StabilizesJanuary 6, 2025 | seekingalpha.comViatris Inc. stock falls Thursday, underperforms marketJanuary 2, 2025 | marketwatch.comViatris Inc. stock rises Tuesday, outperforms marketJanuary 1, 2025 | marketwatch.comViatris Inc. stock falls Friday, still outperforms marketDecember 27, 2024 | marketwatch.comViatris Inc. stock rises Thursday, outperforms marketDecember 27, 2024 | marketwatch.comViatris doesn’t see FDA warning impacting current 2024 financial guidanceDecember 25, 2024 | markets.businessinsider.comViatris confirms receipt of warning letter, import alert for India facilityDecember 25, 2024 | markets.businessinsider.comViatris Inc. stock falls Tuesday, underperforms marketDecember 25, 2024 | marketwatch.comViatris Inc. stock falls Monday, underperforms marketDecember 24, 2024 | marketwatch.comUS FDA sends warning letter to Viatris over India manufacturing facilityDecember 23, 2024 | reuters.comViatris Inc. stock rises Friday, outperforms marketDecember 20, 2024 | marketwatch.comWhat Makes Viatris (VTRS) a Favorite Stock for Billionaire David Einhorn?December 19, 2024 | insidermonkey.comViatris announces publication of CARE study resultsDecember 19, 2024 | markets.businessinsider.comViatris Reports Phase 2b CARE Study Data For Cenerimod - Quick FactsDecember 18, 2024 | markets.businessinsider.comViatris Announces Publication of Phase 2b CARE Study Data for Cenerimod in Lancet RheumatologyDecember 18, 2024 | prnewswire.comViatris Inc. (VTRS) Announces Key Outcomes from 2024 Annual Shareholder MeetingDecember 6, 2024 | gurufocus.comMapi Pharma is Seeking New Depot Product PartnershipsDecember 2, 2024 | globenewswire.comViatris Q3 Earnings TranscriptNovember 28, 2024 | marketbeat.com2 Generic Drug Stocks Ready to Surge in 2025Explore how Teva Pharmaceuticals and Viatris are leading the generics industry with strong growth, robust pipelines, and strategies for 2025 success.November 27, 2024 | marketbeat.comViatris fined £1.5M for failure to comply with CMA orderNovember 22, 2024 | msn.comUK watchdog fines Viatris $1.9 mln over rule breach in Theramex probeNovember 22, 2024 | reuters.comViatris fined in Morocco over merger notification, sources sayNovember 21, 2024 | reuters.comViatris Inc. (VTRS) Management Presents at Jefferies London Healthcare Conference (Transcript)November 21, 2024 | seekingalpha.comViatris Inc. (VTRS) Jefferies London Healthcare Conference (Transcript)November 21, 2024 | seekingalpha.comViatris Inc. (VTRS) UBS Global Healthcare Conference (Transcript)November 15, 2024 | seekingalpha.comViatris Underperform Rating: Limited Growth Prospects and Conservative Capital Allocation StrategyNovember 9, 2024 | markets.businessinsider.comViatris Inc. (NASDAQ:VTRS) Q3 2024 Earnings Call TranscriptNovember 9, 2024 | msn.comViatris price target raised to $12 from $11 at BarclaysNovember 9, 2024 | markets.businessinsider.comBargain Priced Viatris Reports Strong Q3 Earnings ResultsNovember 8, 2024 | seekingalpha.comViatris Inc (VTRS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Debt ...November 8, 2024 | finance.yahoo.comViatris Inc. Reports Strong Q3 2024 PerformanceNovember 8, 2024 | markets.businessinsider.comViatris Inc. Q3 Profit Decreases, But Beats EstimatesNovember 7, 2024 | markets.businessinsider.comGeneric Drugmaker Viatris Beats Expectations In Q3, CEO Praises $2 Billion Debt PaydownNovember 7, 2024 | benzinga.comViatris Tops Analyst Estimates in Q3November 7, 2024 | fool.comViatris nears 11-month high after Q3 beatNovember 7, 2024 | msn.comViatris Inc. (VTRS) Q3 2024 Earnings Call TranscriptNovember 7, 2024 | seekingalpha.comViatris Inc. 2024 Q3 - Results - Earnings Call PresentationNovember 7, 2024 | seekingalpha.comXanax maker Viatris beats quarterly estimates on demand for new generic drugsNovember 7, 2024 | reuters.comViatris Q3 Earnings Preview: Focus on upcoming product launches and EBITDA growthNovember 6, 2024 | msn.comAre Wall Street Analysts Predicting Viatris Stock Will Climb or Sink?November 6, 2024 | msn.comViatris Announces Third Quarter 2024 DividendNovember 5, 2024 | prnewswire.comViatris to Report Q3 Earnings: What's in the Cards?November 4, 2024 | msn.com Get Viatris News Delivered to You Automatically Sign up to receive the latest news and ratings for VTRS and its competitors with MarketBeat's FREE daily newsletter. Email Address VTRS Media Mentions By Week VTRS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VTRS News Sentiment▼0.490.44▲Average Medical News Sentiment VTRS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VTRS Articles This Week▼33▲VTRS Articles Average Week Get Viatris News Delivered to You Automatically Sign up to receive the latest news and ratings for VTRS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Takeda Pharmaceutical News argenx News BioNTech News Teva Pharmaceutical Industries News BeiGene News Summit Therapeutics News Genmab A/S News Intra-Cellular Therapies News Moderna News Dr. Reddy's Laboratories News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VTRS) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump’s Inauguration Shocker: “Move Your Cash Now”Just in the first week after Trump's win, many stocks jumped by double and even triple digits. But now he's...InvestorPlace | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viatris Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viatris With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
